Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma
Article in Journal for ImmunoTherapy of Cancer (April 2024)
The most recent citing publications are shown below. View all 58 publications that cite this research output on Dimensions.
Article in Journal for ImmunoTherapy of Cancer (April 2024)
Preprint in bioRxiv (March 2024)
Book chapter (March 2024)